Saxony Capital Management »

Brainstorm Cell Therapeutics shares owned by Saxony Capital Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Saxony Capital Management from 13F filings

Historical chart of Saxony Capital Management investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Saxony Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Saxony Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.8k 21k 0.27

More positions owned by Saxony Capital Management

Ishares Tr Msci Acwi Etf (ACWI)
Apple (AAPL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Jpmorgan Usd Emg (EMB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Dimensional Etf Trust Inflation Prote (DFIP)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Saxony Capital Management

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics